Eastman Kodak Company (KODK) Q4 2025 Earnings Call Prepared Remarks Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Kodak's earnings call highlights strong financial performance, including significant debt reduction, increased revenue, and improved operational EBITDA. The focus on growth and strategic investments, particularly in AM&C and Pharma divisions, along with a strong cash position, indicate positive momentum. Despite some risks like economic uncertainties and high interest rates, the overall sentiment is positive due to strategic focus on growth and improved financial health, leading to a likely positive stock price movement.
Key Financial Performance
Fourth Quarter Revenue $290 million, an increase of 9% year-over-year. The increase was driven by growth in both AM&C and Print divisions.
Fourth Quarter Gross Profit $67 million, up 31% year-over-year. The increase was attributed to improved pricing and higher volume.
Fourth Quarter Operational EBITDA $22 million, up 144% year-over-year. This was driven by improved pricing and higher volume, partially offset by higher manufacturing costs and global cost increases.
Full Year Revenue $1.069 billion, an increase of $26 million or 2% year-over-year. The increase was driven by streamlined operations, innovation, and smart revenue strategies.
Full Year Gross Profit $235 million, an increase of $29 million or 14% year-over-year. The improvement was due to stronger pricing discipline and operational execution.
Full Year Operational EBITDA $62 million, an increase of $36 million or 138% year-over-year. This was driven by improved pricing, operational efficiencies, and lower inventory reserve adjustments.
Debt Reduction Reduced term loan principal by $303 million, bringing the year-end balance to $200 million. This significantly lowered ongoing interest expense by approximately $40 million annually.
Cash Position at Year-End $337 million, up $136 million from year-end 2024. This was largely due to proceeds from the KRIP settlement and asset reversion, as well as operational improvements.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New product launches in Pharma: Kodak launched 4 new products in the Pharma division, including PBS and Water for Injection.
Commercial Print advancements: The PROSPER 520 moved from controlled introduction to full production. Investments in AI and machine learning were made to enhance customer service.
Brand licensing growth: Kodak's brand licensing continues to grow, especially in Asia, where stores sell Kodak-branded clothes and materials.
Film resurgence: Kodak launched a direct distribution brand of still films, stabilizing the market and increasing reliability for distributors and retailers. Many Oscar nominees were shot on Kodak film.
Operational efficiencies: Kodak reduced over $200 million in operating expenses over the last few years and invested heavily in new infrastructure and products.
Debt reduction: Kodak reduced its debt by $303 million in 2025, significantly lowering interest expenses by $40 million annually.
Focus on growth: Kodak is shifting towards growth with a strong balance sheet, streamlined operations, and investments in new products and infrastructure.
Pharma division goals: The company aims to achieve Class II certification for its Pharma division.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Economic and Geopolitical Uncertainty: The company faces challenges from global economic and geopolitical uncertainties, including pressures on global trade and inflation, which could impact financial performance and operational stability.
Pension-Related Costs: The company incurred $153 million in excise tax expenses related to the pension reversion surplus, which negatively impacted net income for the quarter and year.
Debt Obligations and Interest Rates: Despite reducing debt, the company still faces high interest rates on term loans (12.5%), requiring further paydowns to reduce financial burdens.
Restructuring Costs: A $13 million increase in restructuring costs compared to the prior year reflects ongoing efforts to streamline operations, which could strain short-term financials.
Manufacturing Costs and Global Cost Increases: Higher manufacturing costs and global cost increases, including aluminum prices, have partially offset operational EBITDA improvements.
Regulatory and Compliance Risks: The company is subject to regulatory and compliance risks, as evidenced by the pension reversion process and excise tax obligations.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Future Growth and Strategic Focus: Kodak is poised for growth with a heavily delevered balance sheet, streamlined operations, and investments in new products. The company is focused on driving free cash flow and growth in its three core businesses: Print, Advanced Materials & Chemicals (AM&C), and Brand Licensing.
AM&C Division: The AM&C division is expected to see continued growth, with a 25% revenue increase in Q4 2025. Investments in core competencies and the launch of a direct distribution brand for still films are stabilizing the market. The company anticipates further growth in this segment.
Pharma Division: Kodak is investing in its Pharma division with the goal of achieving Class II certification. The division has launched four new products, including PBS and Water for Injection, and is expected to contribute to future growth.
Commercial Print Division: The Print division is experiencing growth, particularly in North America, with advancements in the Plates division and printing systems. The PROSPER 520 is moving from controlled introduction to full production, and investments in AI and machine learning are expected to improve customer service and margins.
Brand Licensing: Brand licensing continues to grow, contributing significantly to gross profit. The company is expanding its brand presence, particularly in Asia, where Kodak-branded stores are gaining popularity.
Financial Position and Debt Reduction: Kodak has significantly reduced its debt, with plans to further reduce long-term debt by $100 million. The company is in a net positive cash position, which strengthens its ability to execute growth plans.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Cumulative Dividends Payable: The amendments revised the terms of the cumulative dividends payable to a rate of 6% per annum from 4% previously.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AMC
Full
KRIP reversion
KRIP settlement
Kodak cash
Kodak today
Number
Print
Series equity
Slide
Today
amendment
component gain
consumer
conversion
currency basis
debt repayment
debt year
decline reduction
difference
division
equity obligation
excise tax
gain settlement
half
income decline
increase percentage
interest expense
interest rate
investment asset
loss income
noncash change
number
pension reversion
position
reserve period
reversion proceeds
service
settlement KRIP
KODK Transcript
Eastman Kodak Company (KODK) Q4 2025 Earnings Call Prepared Remarks Transcript
Positive3-12
Kodak's earnings call highlights strong financial performance, including significant debt reduction, increased revenue, and improved operational EBITDA. The focus on growth and strategic investments, particularly in AM&C and Pharma divisions, along with a strong cash position, indicate positive momentum. Despite some risks like economic uncertainties and high interest rates, the overall sentiment is positive due to strategic focus on growth and improved financial health, leading to a likely positive stock price movement.
Eastman Kodak Company (KODK) Q3 2025 Earnings Call Prepared Remarks Transcript
Unknown11-7
The earnings call presents a mixed picture. While there is a positive outlook due to the pension reversion process and strategic investments, financial results show a decline in net income and potential risks in execution and market conditions. The 3% revenue increase and improved gross profit are offset by concerns about competitive pressures and regulatory hurdles. The absence of clear guidance in the Q&A and the lack of discussion on shareholder returns further contribute to a neutral sentiment.
Eastman Kodak Company (KODK) Q1 2025 Earnings Call Transcript
Unknown5-8
The earnings call highlights a mixed financial performance with a net loss and declining operational EBITDA, despite stable revenues. The lack of a Q&A session raises transparency concerns. The pension plan termination may reduce debt but is subject to regulatory risk. Economic and supply chain uncertainties, along with a significant cash decrease, further strain financial health. Although there are strategic investments, the overall sentiment leans negative due to financial challenges and lack of clear guidance.
Eastman Kodak Company (NYSE:KODK) Q4 2024 Earnings Call Transcript
Positive3-19
The earnings call highlights strong financial performance with a 10% revenue increase and improved margins. Strategic initiatives in digital imaging and advanced materials are expected to drive future growth. Despite competitive and economic risks, operational efficiencies and cost management are emphasized. The Q&A session reinforced the focus on innovation and efficiency, with positive developments like the tariff outcome and pension plan termination. Overall, the sentiment is positive, with anticipated revenue growth and improved financial metrics supporting a positive stock price movement.
KODK Slides
KODK Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
